Matt Britz
Vorstandsvorsitzender bei Affyimmune Therapeutics, Inc.
Aktive Positionen von Matt Britz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Vorstandsvorsitzender | 19.03.2024 | - |
| Geschäftsführer | 01.01.2022 | - | |
| Corporate Officer/Principal | 01.06.2021 | 01.01.2022 | |
| Präsident | 01.06.2021 | 19.03.2024 |
Karriereverlauf von Matt Britz
Ausbildung von Matt Britz
| University of Massachusetts | Undergraduate Degree |
| Washington University in St. Louis | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Commercial Services |
- Börse
- Insiders
- Matt Britz
- Erfahrung
